In only 6 years, BioSerenity has become one of the world leaders in electrophysiology. The company is currently experiencing a strong growth and was able to impose its leadership in France and in the US, through its range of expertise in electroencephalogram (EEG), electrocardiogram (ECG), and in sleep disorders. Thanks to the financial support of BNP Paribas and Crédit Agricole Champagne Bourgogne, the company will continue USA and European markets exploration.
On April 28, 2021, Idinvest Partners, a wholly-owned subsidiary of Eurazeo since 2020, changed its name to reflect its integral position in the Group.
All activities in the Private Equity, Private Debt and Real Assets businesses now share the single Eurazeo brand.
Find all the information on the Group, its businesses and its commitments on the eurazeo.com website.